Rare diseases
Investigational molecules
Locations
359 conditions with trials, the busiest first
849 trials across Europe, recruiting first
Study on Tebentafusp and Drug Combination for Patients with Advanced Uveal Melanoma
BelgiumStudy on Dantrolene Sodium for Treating Darier Disease in Affected Patients
SwedenStudy on the Safety of Allogeneic Adipose Tissue-Derived Mesenchymal Stromal Cells for Patients with Epidermolysis Bullosa
CzechiaStudy on the Effectiveness and Safety of Barzolvolimab for Patients with Chronic Inducible Urticaria
BulgariaStudy on the Safety and Efficacy of Empasiprubart for Adults with Dermatomyositis
GreeceStudy on Dacarbazine, Pembrolizumab, Nivolumab, and Ipilimumab for Patients with Unresectable or Metastatic Melanoma Resistant to Immunotherapy
GermanyStudy of L19IL2 and L19TNF for Patients with Advanced Basal Cell Carcinoma or Cutaneous Squamous Cell Carcinoma Not Eligible for Surgery or Radiation
GermanyStudy on the Long-Term Safety of STAR-0215 for Adults with Hereditary Angioedema
BulgariaStudy on the Effect of Food on Selumetinib in Adolescents with Neurofibromatosis Type 1 Plexiform Neurofibromas
PolandStudy on Rezpegaldesleukin for Treating Severe Alopecia Areata in Adults
PolandLong-Term Safety Study of Everolimus for Patients with Tuberous Sclerosis Complex and Refractory Seizures
PolandStudy on the Effectiveness of Oxygen Therapy for Patients with Diabetic Foot Ulcers
The NetherlandsThe therapies tested most often in Skin and subcutaneous tissue disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
